STAT+: Pharma’s reputation among patient groups rose last year, but concerns remain over access and pricing

The pharmaceutical industry's reputation among patient groups rose last year, with 57% of over 2,400 groups reporting a positive reputation. However, concerns remain about access and pricing. The industry's reputation is still below its 2022 level.